Protective effects of recombinant human growth hormone on cirrhotic rats

Table 1 Effects of rhGH treatment on various parameters (mean ± SD)

Group	RT (fmol/mg	GHR mRNA	ALB(iOD)	ALT	MDA (nmol/mg	SOD	RCC	PVP
	protein)	(iOD)	(g/L)	(U/L)	protein)	(U/mg)	(%)	(cmH2o)
A	72 ± 12	29 ± 3	35 ± 5	61 ± 10	10.2 ± 1.4	1078 ± 185	1.14 ± 0.21	5.6 ± 0.7
B	80 ± 9c	56 ± 4c	42 ± 7c	55 ± 11	9.4 ± 1.2	1057 ± 159	1.13 ± 0.18	5.8 ± 0.7
C	31 ± 4a	23 ± 3a	29 ± 4a	89 ± 15a	18.7 ± 3.2a	824 ± 108a	22.30 ± 3.86a	14.4 ± 2.0a
D	40 ± 7ac	42 ± 8ac	37 ± 7c	69 ± 7ac	12.0 ± 2.2ac	1029 ± 76c	14.70 ± 2.07ac	9.3 ± 1.5ac

^aP < 0.05 vs control groups A and B,

^cP < 0.05 vs before rhGH treatment (group A or C).